News

Aikido Provides Update on Use of Machine Learning in Drug Development Program

FOR IMMEDIATE RELEASE: Aikido Provides Update on Use of Machine Learning in Drug Development Program NEW YORK, NY August    , 2021 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore School of […]

Continue Reading

Job Opening: Scientific Programmer

SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio.   Immediate Job Opening   Scientific Programmer   July 27, 2021   What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are the management team, the operators, […]

Continue Reading

Job Opening: Machine Learning, Deep Tech Applications

SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision.   Immediate Job Opening   Machine Learning Deep Tech Applications   July 27, 2021   What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We […]

Continue Reading

Job Opening: Full-Stack Developer, Deep Tech Applications

SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision.   Immediate Job Opening   Full-Stack Developer Deep Tech Applications   July 27, 2021   What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We […]

Continue Reading

SilcsBio Joins with NIST and Pharma Partner In Validating SILCS Technology for Biologics Formulation

FOR IMMEDIATE RELEASE:   SilcsBio Joins with NIST and Pharma Partner In Validating SILCS Technology for Biologics Formulation   Scientific collaboration demonstrates effective computational method for stabilizing biologic therapeutics such as antibodies   December 16, 2020, Baltimore, MD – SilcsBio, LLC, a technology company that develops and markets software and services for structure-based drug design, today announced members […]

Continue Reading

SilcsBio and Dalriada Drug Discovery Launch Partnership to Create a Rapid Drug Discovery Service Suite

SilcsBio and Dalriada to tap areas of expertise in drug design and development to accelerate clients’ programs in development of therapeutic treatments against diseases with unmet needs, initiated with COVID-19 FOR IMMEDIATE RELEASE: June 11, 2020, Baltimore, MD and Toronto, ON – SilcsBio, a technology company that develops innovative software and provides services for structure-based […]

Continue Reading